ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks.
AQR Capital Management LLC boosted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 38.2% in the second ...
AtriCure, Inc. (NASDAQ: ATRC) recently announced the receipt of an expanded indication for the AtriClip in CE-marked countries in Europe. The product is now indicated for use in patients at ...
On June 20, 2024, AtriCure, Inc. (NASDAQ:ATRC) stock closed at $23.76 per share with a market capitalization of $1.15 billion ...
A good stock in these conditions often exhibits strong ... There's been a notable change in appetite for AtriCure, Inc. ( NASDAQ:ATRC ) shares in the week since its quarterly ...
Investors in AtriCure Inc (Symbol: ATRC) saw new options begin trading this week, for the November 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATRC ...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
On September 17, 2024, AtriCure, Inc. (NASDAQ:ATRC) stock closed at $28.07 per share with a market capitalization of $1.367 billion. TimesSquare Capital Management U.S. Small Cap Growth Strategy ...
29don MSN
On September 17, 2024, AtriCure, Inc. (NASDAQ:ATRC) stock closed at $28.07 per share with a market capitalization of $1.367 billion. TimesSquare Capital Management U.S. Small Cap Growth Strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback